Abstract |
Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is an inflammatory cytokine that modulates several biological responses by inducing chemokines and proinflammatory cytokines. We hypothesized that TWEAK could promote secretion of IL-17, an amplifier of inflammatory arthritis. To test this, we investigated the capacity of TWEAK to induce IL-17 production in T cells via the fibroblast growth factor-inducible gene 14 (Fn14, also known as TWEAK receptor) signal pathway in rheumatoid arthritis (RA). Fn14 and IL-17 were highly expressed in arthritic tissues of collagen-induced arthritis (CIA) mice. TWEAK induced production of IL-17 alone and synergistically with lipopolysaccharide. In naïve murine T cells, TWEAK promoted Th17 differentiation. The expression of Fn14 was predominant in Th17 cells. TWEAK and IL-17 concentrations were significantly higher in synovial fluid and serum in RA patients than OA patients. In addition, we identified CD4(+)IL-17(+)Fn14(+) cells in synovium from RA patients. TWEAK promoted IL-17 production synergistically with IL-23 or IL-21 and blockade of Fn14 with Fn14-Fc suppressed Th17 differentiation. Conversely, this treatment enhanced Treg differentiation. These results suggest that TWEAK induces IL-17 production and may be a therapeutic target in the treatment of RA.
|
Authors | Jin-Sil Park, Mi-Kyung Park, Seon-Yeong Lee, Hye-Jwa Oh, Mi-Ae Lim, Woo-Tae Cho, Eun-Kyung Kim, Ji-Hyeon Ju, Young-Woo Park, Sung-Hwan Park, Mi-La Cho, Ho-Youn Kim |
Journal | Cytokine
(Cytokine)
Vol. 60
Issue 1
Pg. 143-9
(Oct 2012)
ISSN: 1096-0023 [Electronic] England |
PMID | 22819243
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cytokine TWEAK
- Interleukin-17
- Interleukin-23
- Interleukins
- Lipopolysaccharides
- Receptors, Tumor Necrosis Factor
- Recombinant Proteins
- TNFRSF12A protein, human
- TNFSF12 protein, human
- TWEAK Receptor
- Tnfrsf12a protein, mouse
- Tumor Necrosis Factors
- interleukin-21
|
Topics |
- Animals
- Arthritis, Experimental
(genetics, metabolism)
- Arthritis, Rheumatoid
(blood, genetics, metabolism)
- CD4-Positive T-Lymphocytes
(drug effects, metabolism)
- Cells, Cultured
- Cytokine TWEAK
- Drug Synergism
- Enzyme-Linked Immunosorbent Assay
- Gene Expression
(drug effects)
- Interleukin-17
(blood, genetics, metabolism)
- Interleukin-23
(pharmacology)
- Interleukins
(pharmacology)
- Lipopolysaccharides
(pharmacology)
- Male
- Mice
- Mice, Inbred DBA
- Osteoarthritis
(blood, genetics, metabolism)
- Receptors, Tumor Necrosis Factor
(metabolism)
- Recombinant Proteins
(pharmacology)
- Reverse Transcriptase Polymerase Chain Reaction
- Spleen
(cytology, metabolism)
- TWEAK Receptor
- Tumor Necrosis Factors
(blood, genetics, pharmacology)
|